Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: A pilot study

Hellenic Journal of Cardiology

Volumn 50, Issue 1, 2009, Pages 37-44

  Papadopoulou, Klio ^a   Giannakoulas, Georgios ^a   Karvounis, Haralambos ^a,c   Dalamanga, Emmanouella ^a   Karamitsos, Theodoros ^a,b   Parcharidou, Despina ^a   Damvopoulou, Efthalia ^a   Efthimiadis, Georgios K ^a   Styliadis, Ioannis ^a   Parcharidis, Georgios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Doppler; Echocardiography; Functional mitral regurgitation; Idiopathic dilated cardiomyopathy; Ischaemic cardiomyopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; LUNG ARTERY PRESSURE; MALE; MITRAL VALVE REGURGITATION; PILOT STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOMYOPATHY, DILATED; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 59949084585     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J. 1997; 18: 208-225.
2. Cleland L, Erdmann E, Ferrari R, et al. Guidelines for the diagnosis of heart failure. Eur Heart J. 1995; 16: 741-751.
3. Otsuji Y, Handschumacher MD, Schwanmmenthal E, et al. insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997; 96: 1999-2008.
4. Boudoulas H. Etiology of valvular heart disease in the 21st century. Hellenic J Cardiol. 2002; 43: 183-188.
5. Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol. 1999; 33: 538-545.
6. Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000; 102: 1400-1406.
7. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: Real-time three dimensional echocardiography study. Circulation. 2003; 107: 1135-1140.
8. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989; 2: 358-367.
9. Enriquez-Sarano M, Seward JB, Bailey KR, et al. Effective regurgitant orifice area: a non invasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 1994; 23: 443-451.
10. Enriquez-Sarano M, Miller FAJ, Hayes SN, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995; 25: 703-709.
11. Agricola E, Oppizzi M, Maisano F, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr. 2004; 5: 326-334.
12. Lamas GA, Mitchell GF, Flaker GC, et al; Survival and Ventricular Enlargement investigators. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997; 96: 827-833.
13. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001; 103: 1759-1764.
14. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997; 29: 153-159.
15. Rihal CS, Nishimura RA, Hatle LK, et al. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis. Circulation. 1994; 90: 2772-2779.
16. Amigoni M, Meris A, Thune JJ, et al. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Eur Heart J. 2007; 28: 326-333.
17. Nagasaki M, Nishimura S, Ohtaki E, et al. The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy. int J Cardiol. 2006; 108: 171-176.
18. He S, Fontaine AA, Schwammenthal E, et al. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997; 96: 1826-1834.
19. Bruch C, Klem I, Breithardt G, Wichter T, Gradaus R. Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol. 2007; 100: 860-865.
20. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1991; 68: 355-359.
21. Kaul S, Spotnitz WD, Glasheen WP, et al. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation. 1991; 84: 2167-2180.
22. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992; 20: 1594-1598.
23. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: Three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001; 37: 641-648.
24. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987; 59: 634-638.
25. Ruan Q, Nagueh SF. Usefulness of isovolumic and systolic ejection signals by tissue Doppler for the assessment of left ventricular systolic function in ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2006; 97: 872-875.
26. Parcharidou D, Giannakoulas G, Efthimiadis G, et al. Right ventricular function in ischemic or idiopathic dilated cardiomyopathy. Circ J. 2008; 72: 238-244.
27. Giannakoulas G, Parcharidou D, Efthimiadis G, Karvounis H, Styliadis I, Parcharidis G. Right ventricular dysfunction in chronic heart failure. Am J Cardiol. 2008; 101: 1070
28. Hamdan A, Shapira Y, Bengal T, et al. Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. J Heart Lung Transplant. 2006; 25: 214-218.
29. Acil T, Wichter T, Stypmann J, et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol. 2005; 103: 175-181.
30. Karagiannis SE, Maounis T, Athanassopoulos GD, et al. Cardiac resynchronization therapy decreases the mitral coaptation point displacement in heart failure patients. Hellenic J Cardiol. 2006; 47: 198-205.
31. Kotoulas C, Omorphos S, Sarraf A, Patris K, Hasan R. Mitral valve repair: beyond the French correction. Hellenic J Cardiol. 2008; 49: 329-334.
32. Efremidis M, Sideris A, Xydonas S, et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol. 2008; 49: 19-25.